Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FITE19: PTC299 in hospitalized adults with COVID-19
2020-001872-13Phase 2Terminated
- Sponsor
- PTC Therapeutics, Inc.
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) and acute respiratory illness (ARI) comparing Emvododstat with Placebo (2 arms). Primary endpoint: Time to respiratory improvement. Started Dec 2020; status: terminated.
02
Drugs
emvododstat
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory illness (ARI)
Beyond the preview
Go deeper on 2020-001872-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001872-13.